Investor Presentation: H1 2024 Results

Shareholders Extraordinary Meeting

Closing of the acquisition of remaining 23.86% of UCP

Final payment of Making Science 2021 bond program

Q3 2024 webinar announcement

H1 2024 Financial report

Advance financial information for 9M 2024

Investor Presentation: Q3 2024 Results

Receipt of further €10 million as part of investment agreement with SOPEF

Signing of agreement for investment with SOPEF